XTL Biopharmaceuticals

+$0.04 (+2.23%) As of 5:01 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell XTLB and other ETFs, options, and stocks.

About XTLB

XTL Biopharmaceuticals Ltd. engages in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases. Its pipeline includes hCDR1 and Erythropoietin.

CEO
Shlomo Spokone Shalev
Employees
8
Headquarters
Ramat Gan, HaMerkaz
Founded
1993

XTLB Key Statistics

Market cap
10.49M
Price-Earnings ratio
21.83
Dividend yield
—
Average volume
4.99K
High today
$1.83
Low today
$1.79
Open price
$1.82
Volume
547.00
52 Week high
$6.69
52 Week low
$1.48
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure